Completed NA INTERVENTIONAL 2-arm NCT00725322

Subcutaneous Botulinum Toxin for Cutaneous Allodynia

Sponsor: Stanford University

Conditions Pain

Interventions Botulinum Toxin A Placebo - Saline

Updated 7 times since 2017 Last updated: Oct 23, 2017 Started: Dec 31, 2007 Primary completion: Mar 31, 2013 Completion: Mar 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Pain and is currently completed. Stanford University leads this study, which shows 7 recorded versions since 2007 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Nov 2017 — Jun 2018 [monthly]

Completed NA

Status: Unknown Status → Completed

▶ Show 2 earlier versions

Feb 2017 — Nov 2017 [monthly]

Unknown Status NA
Jan 2017 — Feb 2017 [monthly]

Unknown Status NA

First recorded

Dec 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Stanford University

Data source: Stanford University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Stanford, United States